The European Medicines Agency (EMA) is reviewing six hepatitis C direct acting anti-virals (DAA) for possible hepatitis B re-activation in people with co-infection receiving hepatitis C treatment.
People getting their viral hepatitis medicines from community pharmacies appear to be encountering delays due to "system issues".
The Federal Government's billion dollar investment in new hepatitis C medicines must be supported by a concerted effort to raise public awareness of the ground-breaking treatments, experts say.
Got questions about the new hepatitis C treatments? Get your answers at Hepatitis SA's community forum.
Thinking of doing hepatitis C treatment? Now's the time to take that first step and get yourself ready.
Hepatitis C treatments must reach vulnerable populations with high infection rates, if the hope of halting and eliminating hepatitis C is to be realised, Health Minister Sussan Ley said.
New hepatitis C treatments, Tim's long wait, tips to make your resolutions stick and more.
Three new hepatitis C treatments will be listed on the PBS from 1 March 2016. If you are a health professional managing clients with hepatitis C, what do you need to know?
Women with hepatitis C who consume more cholesterol are at higher risk of liver-related deaths, a recent study has found.
Active chronic hepatitis C increases the risk of major cardiovascular events, independent of the severity of the liver disease or the common cardiovascular risk factors.
Zepatier, a drug that treats hepatitis C genotype 1 in people with end-stage renal disease, has been withdrawn from the March meeting of the Pharmaceutical Benefits Advisory Committee (PBAC).
